ArticleJournal of surgical case reports2025
Giant atypical meningioma diagnosis and clinical treatment: a case report.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant atypical meningioma (WHO grade 2), predominantly female-associated and rare in males. A 23-year-old male presented with episodic limb paralysis and progressive vision/olfaction decline. Magnetic resonance imaging (MRI) revealed a > 8 cm heterogeneously enhancing tumor invading the diploic space with multi-site compression. Preoperative embolization followed by subtotal resection and adjuvant gamma knife radiosurgery achieved 3-year recurrence-free survival. This case highlights: (i) exceptional rarity of young male onset, challenging epidemiological patterns and (ii) the combined strategy of embolization, subtotal resection, and radiotherapy may overcome traditional high recurrence rates in atypical meningiomas, offering insights for individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.